MRI scan to see immune cells in lymphoma
Part of Blood & lymphatic, Cancer clinical trials.
This trial tests a special MRI technique that uses an iron-based contrast agent to see immune cells (macrophages) around lymphoma tumors. It may help doctors better understand and track the disease, which could guide future treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of lymphoma called DLBCL that has come back or not responded to treatment.
- You have at least one area of lymphoma that shows up on a recent scan (like CT, MRI, PET, or ultrasound).
- You are 18 years old or older.
- You are not pregnant or breast-feeding (and if you could become pregnant, you will need a negative pregnancy test).
- You do not have anemia, kidney problems, any reason you cannot have an MRI, or an allergy to iron products.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the biology of certain lymphomas to better understand why some people respond well to treatment and others don't. It involves giving a small additional blood or tissue sample to help researchers find genetic clues that could improve future care.
This trial tests a combination of radiation, immune-boosting drugs, and a targeted antibody for people newly diagnosed with primary central nervous system diffuse large B-cell lymphoma (a type of brain lymphoma). The goal is to see if this approach is safe and effective.
This study looks at how certain blood tests (like CRP, albumin, and their ratios) might help predict how well treatment works for newly diagnosed DLBCL. If you are getting R-CHOP, this trial could help doctors better understand your response to therapy.
This trial tests a new type of imaging scan to see if it can better detect and monitor brain lymphoma. It may help doctors tailor treatment by seeing how the cancer responds early on.
This trial tests whether two special MRI contrast medicines—gadolinium and ferumoxytol—can better diagnose problems in the brain or central nervous system. It may help doctors identify what’s causing symptoms or abnormal brain findings.
This trial uses a special PET scan to see if a protein called Granzyme B can predict how well immunotherapy will work for people with DLBCL. It aims to help doctors know earlier if treatment is effective.
Hear when a new DLBCL - Diffuse Large B Cell Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.